Dostawy produktów leczniczych stosowanych w programach lekowych i chemioterapii
7 suppliers awarded•20 lots awarded•€1.89M awarded
Buyer: Samodzielny Publiczny Zakład Opieki Zdrowotnej Wojewódzki Szpital Specjalistyczny Nr 3 w Rybniku / Rybnik, Poland
Awarded value
€1.89M
Estimated value
€1.89M
Awarded at 100% of estimated value
Award date
Jan 29, 2024
Winners
7
Lots awarded
20
Award values
Notice total
€1.89M
Sum of lot awards
€1.86M
TED notice total and lot-level values do not exactly match.
Winners
Warszawa, POL
€620,812 This contract
15 award notices•21 awarded lots•€4.84M total
Warszawa, POL
€219,865 This contract
15 award notices•26 awarded lots•€10.41M total
Warszawa, POL
€207,821 This contract
143 award notices•206 awarded lots•€26.17M total
Wrocław, POL
€199,765 This contract
499 award notices•1,666 awarded lots•€342.93M total
Wrocław, POL
€102,692 This contract
89 award notices•281 awarded lots•€8.64M total
Warszawa, POL
€70,404 This contract
65 award notices•105 awarded lots•€20.61M total
Warszawa, POL
€7,828 This contract
32 award notices•52 awarded lots•€1.11M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0061 | Janssen-Cilag Polska sp. z o.o. | €620,812 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0062 | Not specified | €230,140 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0060 | Roche Polska Sp. z o.o. | €207,821 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0059 | URTICA Sp. z o.o. | €195,501 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0054 | Roche Polska Sp. z o. o. | €153,351 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0055 | Not specified | €153,351 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0058 | Amgen Sp. z o.o. | €70,404 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0057 | Roche Polska Sp. z o. o. | €66,514 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0064 | ASCLEPIOS S.A. | €61,602 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0065 | Not specified | €52,143 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0048 | ASCLEPIOS S.A. | €37,171 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0046 | BAXTER POLSKA Sp. z o.o. | €4,588 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0051 | URTICA Sp. z o.o. | €4,264 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0047 | ASCLEPIOS S.A. | €3,919 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0050 | BAXTER POLSKA Sp. z o.o. | €3,240 | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0049 | Not specified | — | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0052 | Not specified | — | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0053 | Not specified | — | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0056 | Roche Polska Sp. z o. o. | — | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0063 | ASCLEPIOS S.A. | — | Antineoplastic and immunomodulating agents (33652000) |